ICU Medical Inc
$ 142.00
3.29%
09 Jun - close price
- Market Cap 3,436,118,000 USD
- Current Price $ 142.00
- High / Low $ 142.36 / 138.58
- Stock P/E 73.52
- Book Value 84.50
- EPS 1.87
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.02 %
- 52 Week High 160.29
- 52 Week Low 107.00
About
ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
Analyst Target Price
$172.86
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-19 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-27 | 2024-11-12 | 2024-08-07 | 2024-05-07 | 2024-02-27 | 2023-11-06 | 2023-08-07 |
| Reported EPS | 1.97 | 1.91 | 2.03 | 2.1 | 1.72 | 2.11 | 1.59 | 1.56 | 0.96 | 1.57 | 1.57 | 1.88 |
| Estimated EPS | 1.75 | 1.69 | 1.43 | 1.5 | 1.28 | 1.482 | 1.25 | 1 | 0.82 | 1.19 | 1.39 | 1.6 |
| Surprise | 0.22 | 0.22 | 0.6 | 0.6 | 0.44 | 0.628 | 0.34 | 0.56 | 0.14 | 0.38 | 0.18 | 0.28 |
| Surprise Percentage | 12.5714% | 13.0178% | 41.958% | 40% | 34.375% | 42.3752% | 27.2% | 56% | 17.0732% | 31.9328% | 12.9496% | 17.5% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.91 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ICUI
2026-06-08 20:09:26
ICU Medical Inc recently reported its latest quarterly figures and is continuing the integration of its Smiths Medical acquisition, while managing a mixed demand and margin environment. The article details the company's core business model, key revenue and product drivers, and what its numbers and guidance mean for investors. It notes ICU Medical's focus on infusion therapy, oncology, and critical care products, highlighting its recurring revenue model from disposable components and its strategic contracts with healthcare organizations.
2026-06-04 22:34:00
This article provides a detailed analysis of Icu Medical Inc. (ICUI) focusing on risk zones and trading strategies based on AI models. It highlights conflicting sentiment across different time horizons, suggesting choppy conditions, and offers specific position trading, momentum breakout, and risk hedging strategies with entry points, targets, and stop losses. The analysis also includes multi-timeframe signal strength, support, and resistance levels for the stock.
2026-06-04 08:13:19
ICU Medical Inc. (ICUI) is currently considered undervalued, with its fair price estimated to be between $168.98 and $254.95, compared to its current price of $130.52. Despite this, its P/S ratio of 1.43 is significantly above the industry average, which, coupled with a -12.32% revenue growth, suggests this premium may be unsustainable. The article provides detailed valuation metrics such as P/B ratio, FCF yield, and forward P/E and P/S ratios to support this assessment.
2026-06-01 14:13:18
ICU Medical shareholders recently approved significant governance changes, including the removal of supermajority voting thresholds and the ability for investors holding at least 25% of voting power to call special meetings. These changes aim to increase shareholder influence and reflect an incremental cleanup of the company's governance structure. While these shifts don't immediately impact earnings, they reshape how quickly shareholders can react if operational efforts fall short of expectations, against a backdrop of the company recently returning to profitability and projecting future revenue and earnings growth.
2026-06-01 07:10:39
ICU Medical shareholders recently approved amendments to the company's charter and bylaws, removing supermajority voting thresholds and granting investors holding at least 25% of voting power the ability to call special meetings. This shift, while seen as an incremental governance improvement, suggests rising shareholder influence. The changes primarily impact how quickly shareholders can react if the company's integration, restructuring, or new product launches do not meet expectations, rather than immediately affecting near-term earnings.
2026-05-28 14:13:19
ICU Medical (ICUI) has implemented significant governance changes, lowering the threshold for shareholder-initiated special meetings and ordinary resolutions. Despite a recent boost in share price, the company's 3-year and 5-year total shareholder returns are down. The article explores whether the stock, currently trading below its estimated fair value of $180.17, presents a genuine investment opportunity or if its high P/E ratio signals valuation risks.
